Literature DB >> 2688444

Colony-stimulating factor in middle ear cholesteatoma.

T Huang1, S D Yan, C C Huang.   

Abstract

Granulocyte-macrophage colony stimulating factor (GM-CSF) was found in human middle ear cholesteatoma tissues by immunohistochemical technique using mouse monoclonal anti-(human) GM-CSF IgG. Immunofluorescent staining showed the presence of GM-CSF in the peribasal area, in some suprabasal cells of the epithelium, and in the inflammatory connective tissue, especially in the monocytes and fibroblasts. These findings were confirmed by the immunoperoxidase method. Staining of the external ear canal epithelium, however, was significantly weaker than that of the cholesteatoma epithelium. The presence of GM-CSF in cholesteatoma appears to be a response to inflammation occurring in the middle ear cavity. Moreover, our in vitro study showed that GM-CSF induced the proliferation and protein synthesis of basal keratinocytes. This study suggests that GM-CSF is involved in the development and destructive effects of middle ear cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688444     DOI: 10.1016/0196-0709(89)90034-3

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  9 in total

1.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma.

Authors:  K Hochstrasser; G J Albrecht; W Gebhard; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

3.  Platelet-derived growth factor in middle ear cholesteatoma.

Authors:  O Fujioka; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 4.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

5.  Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.

Authors:  H Shinoda; C C Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  The c-MYC protooncogene expression in cholesteatoma.

Authors:  Enikő Palkó; Szilárd Póliska; Zsuzsanna Csákányi; Gábor Katona; Tamás Karosi; Frigyes Helfferich; András Penyige; István Sziklai
Journal:  Biomed Res Int       Date:  2014-02-10       Impact factor: 3.411

7.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

8.  Establishment and characterization of an in vitro model for cholesteatoma.

Authors:  Alexander M Raynov; Yun-Hoon Choung; Hun Yi Park; Seong Jun Choi; Keehyun Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-06-20       Impact factor: 3.372

Review 9.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.